Stockreport

N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination

N2OFF, Inc.  (NITO) 
PDF Neve Yarak, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF”), a cleantech company investing in solar energy assets based on the RTB (Read [Read more]